[Mobile application "Aterostop" for a comprehensive assessment of cardiovascular risk in patients in the Russian population].
I V SergienkoA A AnshelesSergey A BoytsovPublished in: Terapevticheskii arkhiv (2021)
The article provides an overview of an innovative software product for a comprehensive assessment of cardiovascular risk in cardiac patients in the Russian Federation. Based on the new recommendations of the Russian National Atherosclerosis Society (2020), the Aterostop application allows to assess cardiovascular risk, determine the patients achievement of target levels of low-density lipoprotein cholesterol, and also provides recommendations for correcting lipid-lowering therapy. The calculator is implemented as a web browser version, as well as a mobile application for Android and iOS platforms.